Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioDelivery Announces Completion of Trial; Catalyst Could Invigorate Share Price
BioDelivery Announces Completion of Trial; Catalyst Could Invigorate Share Price
BioDelivery Announces Completion of Trial; Catalyst Could Invigorate Share Price
Submitted by
admin
on July 27, 2011 - 10:38am
Source:
Seeking Alpha
News Tags:
BioDelivery Sciences
BEMA Buprenorphine
chronic pain
Headline:
BioDelivery Announces Completion of Trial; Catalyst Could Invigorate Share Price
Do Not Allow Advertisers to Use My Personal information
